(Q39848254)

15 September 2017

title

Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas (English)

1 reference

15 September 2017

1 reference

L Vardouli

1

1 reference

15 September 2017

C Lindqvist

2

1 reference

15 September 2017

K Vlahou

3

1 reference

15 September 2017

A S I Loskog

4

1 reference

15 September 2017

A G Eliopoulos

5

1 reference

15 September 2017

publication date

22 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

848-860

1 reference

CD40 and its ligand in host defense

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

A novel function of CD40: induction of cell death in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

The role of the CD40 pathway in the pathogenesis and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Prospects for CD40-directed experimental therapy of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Differential regulation of cell survival by CD40

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FCGT.2009.31

21 January 2018

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Identity of some human bladder cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Cancer gene therapy using a novel secretable trimeric TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Differential regulation of soluble and membrane CD40L proteins in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Biophysical characterization of a soluble CD40 ligand (CD154) coiled-coil trimer: evidence of a reversible acid-denatured molten globule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

CD40 ligand and its role in X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

CD40 expression on human lung cancer correlates with metastatic spread

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Effects of loss of p53 and p16 function on life span and survival of human urothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Phase I study of recombinant human CD40 ligand in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

The statistics of synergism

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.31

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.31

1 reference

Dimensions Publication ID

15 September 2017

1015969985

0 references

1 reference